Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oruka Therapeutics (ORKA) Amortization of Deferred Charges (2014 - 2020)

Oruka Therapeutics' quarterly Amortization of Deferred Charges came in at $22000.0 in Q1 2020, up 37.5% year-on-year from $16000.0 in Q2 2019, and little changed quarter-over-quarter from $22000.0 in Q4 2019.

Oruka Therapeutics has reported Amortization of Deferred Charges for 4 years, with the latest figure at $22000.0 in Q1 2020.

  • For the quarter ending Q1 2020, Amortization of Deferred Charges rose 37.5% year-over-year to $22000.0; the trailing twelve-month figure through Mar 2020 stood at $77000.0 (down 55.75% YoY), and the FY2024 full-year result was $1.5 million, changed N/A from the prior year.
  • Amortization of Deferred Charges for Q1 2020 stood at $22000.0, roughly flat from $22000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $22000.0 in Q4 2019, with the low at $16000.0 in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2020 22,000.00
Mar 31, 2020 22,000.00
Dec 31, 2019 22,000.00
Dec 31, 2019 22,000.00
Sep 30, 2019 17,000.00
Sep 30, 2019 17,000.00
Jun 30, 2019 16,000.00
Jun 30, 2019 16,000.00
Mar 31, 2019 16,000.00
Mar 31, 2019 16,000.00
Dec 31, 2015 56,000.00
Dec 31, 2015 56,000.00
Sep 30, 2015 55,000.00
Sep 30, 2015 55,000.00
Jun 30, 2015 47,000.00
Jun 30, 2015 47,000.00
Mar 31, 2015 31,000.00
Mar 31, 2015 31,000.00
Dec 31, 2014 33,000.00
Dec 31, 2014 33,000.00